Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (191-200 of 279) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Bone Marrow Transplantation|January 1, 1993
Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter surveyC Weyman, J Graham-Pole, S Emerson, et al.
Bone Marrow Transplantation|July 1, 1994
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaH M Kantarjian, M Talpaz, B Andersson, et al.
British Journal of Haematology|September 1, 1994
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donorsG Schiller, S A Feig, M Territo, et al.
Transfusion|July 1, 1996
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresP Anderlini, D Przepiorka, D Seong, et al.
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipientsQ Nguyen, R Champlin, S Giralt, et al.
Bone Marrow Transplantation|January 1, 1997
Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxisV A Nicholson, E Whimbey, R Champlin, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Pageof 28

Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Bone Marrow Transplantation|January 1, 1993
Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter surveyC Weyman, J Graham-Pole, S Emerson, et al.
Bone Marrow Transplantation|July 1, 1994
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaH M Kantarjian, M Talpaz, B Andersson, et al.
British Journal of Haematology|September 1, 1994
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donorsG Schiller, S A Feig, M Territo, et al.
Transfusion|July 1, 1996
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresP Anderlini, D Przepiorka, D Seong, et al.
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipientsQ Nguyen, R Champlin, S Giralt, et al.
Bone Marrow Transplantation|January 1, 1997
Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxisV A Nicholson, E Whimbey, R Champlin, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Blood|December 31, 1997
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapyE J Shpall, C F LeMaistre, K Holland, et al.
Pageof 28